The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Opioid Induced Constipation (OIC) Drugs Revenue 1.5 Market Analysis by Type 1.5.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 Lubiprostone 1.5.3 Methyl Naltrexone Bromide 1.5.4 Naldemedine 1.5.5 Alvimopan 1.5.6 Other 1.6 Market by Application 1.6.1 Global Opioid Induced Constipation (OIC) Drugs Market Share by Application: 2021-2026 1.6.2 Hospital Pharmacies 1.6.3 Retail Pharmacies 1.6.4 Online Pharmacies 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Opioid Induced Constipation (OIC) Drugs Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Opioid Induced Constipation (OIC) Drugs Market Players Profiles 3.1 Ironwood Pharmaceuticals Inc 3.1.1 Ironwood Pharmaceuticals Inc Company Profile 3.1.2 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Specification 3.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 Purdue Pharma 3.2.1 Purdue Pharma Company Profile 3.2.2 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product Specification 3.2.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 Progenics Pharmaceuticals Inc 3.3.1 Progenics Pharmaceuticals Inc Company Profile 3.3.2 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Specification 3.3.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 Daiichi Sankyo Co Ltd 3.4.1 Daiichi Sankyo Co Ltd Company Profile 3.4.2 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product Specification 3.4.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 Nektar Therapeutics 3.5.1 Nektar Therapeutics Company Profile 3.5.2 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product Specification 3.5.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 Pfizer 3.6.1 Pfizer Company Profile 3.6.2 Pfizer Opioid Induced Constipation (OIC) Drugs Product Specification 3.6.3 Pfizer Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Mundipharma International Limited 3.7.1 Mundipharma International Limited Company Profile 3.7.2 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product Specification 3.7.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 Allergan Plc 3.8.1 Allergan Plc Company Profile 3.8.2 Allergan Plc Opioid Induced Constipation (OIC) Drugs Product Specification 3.8.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 Shionogi & Co., Ltd 3.9.1 Shionogi & Co., Ltd Company Profile 3.9.2 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Specification 3.9.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.10 S.L.A. Pharma AG 3.10.1 S.L.A. Pharma AG Company Profile 3.10.2 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product Specification 3.10.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.11 Cosmo Pharmaceuticals SA 3.11.1 Cosmo Pharmaceuticals SA Company Profile 3.11.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product Specification 3.11.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.12 Sucampo Pharmaceuticals 3.12.1 Sucampo Pharmaceuticals Company Profile 3.12.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product Specification 3.12.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.13 Ono Pharmaceutical Co., Ltd 3.13.1 Ono Pharmaceutical Co., Ltd Company Profile 3.13.2 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Specification 3.13.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.14 Daewoong Pharmaceutical 3.14.1 Daewoong Pharmaceutical Company Profile 3.14.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product Specification 3.14.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.15 Bausch Health 3.15.1 Bausch Health Company Profile 3.15.2 Bausch Health Opioid Induced Constipation (OIC) Drugs Product Specification 3.15.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.16 Takeda Pharmaceutical Company Limited 3.16.1 Takeda Pharmaceutical Company Limited Company Profile 3.16.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product Specification 3.16.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.17 C.B. Fleet Company 3.17.1 C.B. Fleet Company Company Profile 3.17.2 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product Specification 3.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.18 Theravance Biopharma Inc 3.18.1 Theravance Biopharma Inc Company Profile 3.18.2 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product Specification 3.18.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Opioid Induced Constipation (OIC) Drugs Market Competition by Market Players 4.1 Global Opioid Induced Constipation (OIC) Drugs Production Capacity Market Share by Market Players (2015-2020) 4.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Market Players (2015-2020) 4.3 Global Opioid Induced Constipation (OIC) Drugs Average Price by Market Players (2015-2020) 5 Global Opioid Induced Constipation (OIC) Drugs Production by Regions (2015-2020) 5.1 North America 5.1.1 North America Opioid Induced Constipation (OIC) Drugs Market Size (2015-2020) 5.1.2 Opioid Induced Constipation (OIC) Drugs Key Players in North America (2015-2020) 5.1.3 North America Opioid Induced Constipation (OIC) Drugs Market Size by Type (2015-2020) 5.1.4 North America Opioid Induced Constipation (OIC) Drugs Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia Opioid Induced Constipation (OIC) Drugs Market Size (2015-2020) 5.2.2 Opioid Induced Constipation (OIC) Drugs Key Players in East Asia (2015-2020) 5.2.3 East Asia Opioid Induced Constipation (OIC) Drugs Market Size by Type (2015-2020) 5.2.4 East Asia Opioid Induced Constipation (OIC) Drugs Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe Opioid Induced Constipation (OIC) Drugs Market Size (2015-2020) 5.3.2 Opioid Induced Constipation (OIC) Drugs Key Players in Europe (2015-2020) 5.3.3 Europe Opioid Induced Constipation (OIC) Drugs Market Size by Type (2015-2020) 5.3.4 Europe Opioid Induced Constipation (OIC) Drugs Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia Opioid Induced Constipation (OIC) Drugs Market Size (2015-2020) 5.4.2 Opioid Induced Constipation (OIC) Drugs Key Players in South Asia (2015-2020) 5.4.3 South Asia Opioid Induced Constipation (OIC) Drugs Market Size by Type (2015-2020) 5.4.4 South Asia Opioid Induced Constipation (OIC) Drugs Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia Opioid Induced Constipation (OIC) Drugs Market Size (2015-2020) 5.5.2 Opioid Induced Constipation (OIC) Drugs Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia Opioid Induced Constipation (OIC) Drugs Market Size by Type (2015-2020) 5.5.4 Southeast Asia Opioid Induced Constipation (OIC) Drugs Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East Opioid Induced Constipation (OIC) Drugs Market Size (2015-2020) 5.6.2 Opioid Induced Constipation (OIC) Drugs Key Players in Middle East (2015-2020) 5.6.3 Middle East Opioid Induced Constipation (OIC) Drugs Market Size by Type (2015-2020) 5.6.4 Middle East Opioid Induced Constipation (OIC) Drugs Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa Opioid Induced Constipation (OIC) Drugs Market Size (2015-2020) 5.7.2 Opioid Induced Constipation (OIC) Drugs Key Players in Africa (2015-2020) 5.7.3 Africa Opioid Induced Constipation (OIC) Drugs Market Size by Type (2015-2020) 5.7.4 Africa Opioid Induced Constipation (OIC) Drugs Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania Opioid Induced Constipation (OIC) Drugs Market Size (2015-2020) 5.8.2 Opioid Induced Constipation (OIC) Drugs Key Players in Oceania (2015-2020) 5.8.3 Oceania Opioid Induced Constipation (OIC) Drugs Market Size by Type (2015-2020) 5.8.4 Oceania Opioid Induced Constipation (OIC) Drugs Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America Opioid Induced Constipation (OIC) Drugs Market Size (2015-2020) 5.9.2 Opioid Induced Constipation (OIC) Drugs Key Players in South America (2015-2020) 5.9.3 South America Opioid Induced Constipation (OIC) Drugs Market Size by Type (2015-2020) 5.9.4 South America Opioid Induced Constipation (OIC) Drugs Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World Opioid Induced Constipation (OIC) Drugs Market Size (2015-2020) 5.10.2 Opioid Induced Constipation (OIC) Drugs Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World Opioid Induced Constipation (OIC) Drugs Market Size by Type (2015-2020) 5.10.4 Rest of the World Opioid Induced Constipation (OIC) Drugs Market Size by Application (2015-2020) 6 Global Opioid Induced Constipation (OIC) Drugs Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America Opioid Induced Constipation (OIC) Drugs Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Opioid Induced Constipation (OIC) Drugs Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Opioid Induced Constipation (OIC) Drugs Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Opioid Induced Constipation (OIC) Drugs Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Opioid Induced Constipation (OIC) Drugs Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Opioid Induced Constipation (OIC) Drugs Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Opioid Induced Constipation (OIC) Drugs Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Opioid Induced Constipation (OIC) Drugs Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Opioid Induced Constipation (OIC) Drugs Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Opioid Induced Constipation (OIC) Drugs Consumption by Countries 7 Global Opioid Induced Constipation (OIC) Drugs Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of Opioid Induced Constipation (OIC) Drugs (2021-2026) 7.2 Global Forecasted Revenue of Opioid Induced Constipation (OIC) Drugs (2021-2026) 7.3 Global Forecasted Price of Opioid Induced Constipation (OIC) Drugs (2021-2026) 7.4 Global Forecasted Production of Opioid Induced Constipation (OIC) Drugs by Region (2021-2026) 7.4.1 North America Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026) 7.4.2 East Asia Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026) 7.4.3 Europe Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026) 7.4.4 South Asia Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026) 7.4.6 Middle East Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026) 7.4.7 Africa Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026) 7.4.8 Oceania Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026) 7.4.9 South America Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World Opioid Induced Constipation (OIC) Drugs Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Application (2021-2026) 8 Global Opioid Induced Constipation (OIC) Drugs Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country 8.2 East Asia Market Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country 8.3 Europe Market Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Countriy 8.4 South Asia Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country 8.5 Southeast Asia Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country 8.6 Middle East Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country 8.7 Africa Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country 8.8 Oceania Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country 8.9 South America Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country 8.10 Rest of the world Forecasted Consumption of Opioid Induced Constipation (OIC) Drugs by Country 9 Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2015-2026) 9.1 Global Opioid Induced Constipation (OIC) Drugs Historic Market Size by Type (2015-2020) 9.2 Global Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Type (2021-2026) 10 Global Opioid Induced Constipation (OIC) Drugs Consumption by Application (2015-2026) 10.1 Global Opioid Induced Constipation (OIC) Drugs Historic Market Size by Application (2015-2020) 10.2 Global Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Application (2021-2026) 11 Global Opioid Induced Constipation (OIC) Drugs Manufacturing Cost Analysis 11.1 Opioid Induced Constipation (OIC) Drugs Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs 12 Global Opioid Induced Constipation (OIC) Drugs Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Opioid Induced Constipation (OIC) Drugs Distributors List 12.3 Opioid Induced Constipation (OIC) Drugs Customers 12.4 Opioid Induced Constipation (OIC) Drugs Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 221 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 260 |
Price : US$ 3,500 | Date : Dec 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 115 |
Price : US$ 2,450 | Date : Dec 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 230 |
Price : US$ 3,500 | Date : Nov 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 100 |
We will be happy to help you find what you need. Please call us or write to us: